Tags : Complaint

Biosimilars

Genentech Files Complaint Against Centus Over Proposed Bevacizumab Biosimilar

Shots: Genentech filed a complaint in the Eastern District of Texas alleging that the proposed biosimilar to Avastin (bevacizumab) product infringes 10 US patents Genentech alleges that Centus and partners failed to disclose sufficient information about the proposed biosimilar to enable Genentech to do a sufficient analysis of potential patent infringements Centus has a BLA […]Read More